Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
Nanox (NASDAQ: NNOX), a medical imaging technology company, has scheduled its fourth quarter and fiscal year 2024 financial results announcement for March 31, 2025, before market open. The company will host a conference call at 8:30 a.m. ET featuring CEO and Acting Chairman Erez Meltzer and CFO Ran Daniel to discuss the results and provide a business update.
Nanox (NASDAQ: NNOX), un'azienda di tecnologia per l'imaging medico, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'anno fiscale 2024 per 31 marzo 2025, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica alle 8:30 ET con il CEO e Presidente ad interim Erez Meltzer e il CFO Ran Daniel per discutere i risultati e fornire un aggiornamento sull'attività.
Nanox (NASDAQ: NNOX), una empresa de tecnología de imágenes médicas, ha programado el anuncio de los resultados financieros del cuarto trimestre y del año fiscal 2024 para el 31 de marzo de 2025, antes de la apertura del mercado. La empresa llevará a cabo una conferencia telefónica a las 8:30 a.m. ET con el CEO y Presidente interino Erez Meltzer y el CFO Ran Daniel para discutir los resultados y proporcionar una actualización del negocio.
Nanox (NASDAQ: NNOX), 의료 영상 기술 회사,는 2025년 3월 31일에 2024 회계연도 4분기 재무 결과 발표를 시장 개장 전에 예정했습니다. 이 회사는 동부 표준시 오전 8시 30분에 CEO이자 임시 의장인 Erez Meltzer와 CFO인 Ran Daniel이 참석하는 컨퍼런스 콜을 개최하여 결과를 논의하고 비즈니스 업데이트를 제공할 예정입니다.
Nanox (NASDAQ: NNOX), une entreprise de technologie d'imagerie médicale, a prévu l'annonce de ses résultats financiers pour le quatrième trimestre et l'exercice 2024 pour le 31 mars 2025, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 8h30 ET avec le PDG et président par intérim Erez Meltzer et le directeur financier Ran Daniel pour discuter des résultats et fournir une mise à jour sur les activités.
Nanox (NASDAQ: NNOX), ein Unternehmen für medizinische Bildgebungstechnologie, hat die Bekanntgabe der finanziellen Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 für den 31. März 2025 vor Markteröffnung angesetzt. Das Unternehmen wird eine Telefonkonferenz um 8:30 Uhr ET abhalten, an der CEO und amtierender Vorsitzender Erez Meltzer sowie CFO Ran Daniel teilnehmen, um die Ergebnisse zu besprechen und ein Update zum Geschäft zu geben.
- None.
- None.
PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. The live webcast of the conference call may be accessed by using the following link: Nanox Q4 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.
Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, is an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision.
Contacts
Media Contact
ICR Healthcare
NanoxPR@icrinc.com
Investor Contact
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
FAQ
When will Nanox (NNOX) release its Q4 2024 earnings report?
What time is the Nanox (NNOX) Q4 2024 earnings conference call?
Who will be presenting at the Nanox (NNOX) Q4 2024 earnings call?
How can investors access the Nanox (NNOX) Q4 2024 earnings call?
